258 related articles for article (PubMed ID: 22821399)
1. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study.
Campana LG; Valpione S; Falci C; Mocellin S; Basso M; Corti L; Balestrieri N; Marchet A; Rossi CR
Breast Cancer Res Treat; 2012 Aug; 134(3):1169-78. PubMed ID: 22821399
[TBL] [Abstract][Full Text] [Related]
2. Electrochemotherapy for disseminated superficial metastases from malignant melanoma.
Campana LG; Valpione S; Mocellin S; Sundararajan R; Granziera E; Sartore L; Chiarion-Sileni V; Rossi CR
Br J Surg; 2012 Jun; 99(6):821-30. PubMed ID: 22508342
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.
Campana LG; Mocellin S; Basso M; Puccetti O; De Salvo GL; Chiarion-Sileni V; Vecchiato A; Corti L; Rossi CR; Nitti D
Ann Surg Oncol; 2009 Jan; 16(1):191-9. PubMed ID: 18987914
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction.
Chagpar A; Langstein HN; Kronowitz SJ; Singletary SE; Ross MI; Buchholz TA; Hunt KK; Kuerer HM
Am J Surg; 2004 Feb; 187(2):164-9. PubMed ID: 14769300
[TBL] [Abstract][Full Text] [Related]
6. Electrochemotherapy of chest wall breast cancer recurrence.
Sersa G; Cufer T; Paulin SM; Cemazar M; Snoj M
Cancer Treat Rev; 2012 Aug; 38(5):379-86. PubMed ID: 21856080
[TBL] [Abstract][Full Text] [Related]
7. Chest wall resection in the treatment of locally recurrent breast carcinoma: indications and outcome for 44 patients.
Faneyte IF; Rutgers EJ; Zoetmulder FA
Cancer; 1997 Sep; 80(5):886-91. PubMed ID: 9307188
[TBL] [Abstract][Full Text] [Related]
8. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
9. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
10. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
11. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
Renner H; van Kampen M
Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
14. Electrochemotherapy in the Treatment of Cutaneous Metastases from Breast Cancer: A Multicenter Cohort Analysis.
Cabula C; Campana LG; Grilz G; Galuppo S; Bussone R; De Meo L; Bonadies A; Curatolo P; De Laurentiis M; Renne M; Valpione S; Fabrizio T; Solari N; Guida M; Santoriello A; D'Aiuto M; Agresti R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S442-50. PubMed ID: 26242370
[TBL] [Abstract][Full Text] [Related]
15. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy.
Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2010 Feb; 33(1):23-7. PubMed ID: 19704369
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy.
Mignano JE; Gage I; Piantadosi S; Ye X; Henderson G; Dooley WC
Am J Clin Oncol; 2007 Oct; 30(5):466-72. PubMed ID: 17921705
[TBL] [Abstract][Full Text] [Related]
19. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
20. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.
Matthiessen LW; Johannesen HH; Hendel HW; Moss T; Kamby C; Gehl J
Acta Oncol; 2012 Jul; 51(6):713-21. PubMed ID: 22731832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]